Biological and virologic characteristics of primary HIV infection

Annals of Internal Medicine

Volumn 128, Issue 8, 1998, Pages 613-620

  Schacker, Timothy W ^a,c   Hughes, James P ^a   Shea, Theresa ^a,d   Coombs, Robert W ^a   Corey, Lawrence ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d University of Washington ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; VIRUS CELL INTERACTION; VIRUS LOAD;

EID: 0032522379     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-8-199804150-00001     Document Type: Article

References (12)

1. Fox R. Eldred LJ, Fuchs EJ, Kaslow RA, Visscher ER, Ho M, et al. Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men. AIDS. 1987;1:35-8.
2. Kinloch-de Loes S, de Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis. 1993;17:59-65.
3. Tindall B, Barker S, Donovan B, Barnes T, Roberts J, Kronenberg C, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med. 1988;148:945-9.
4. Rabeneck L, Popovic M, Gartner S. McLean DM, McLeod WA, Read E, et al. Acute HIV infection presenting with painful swallowing and esophageal ulcers. JAMA. 1990;263:2318-22.
5. Bartelsman JF, Lange JM, van Leeuwen R. van den Tweel JG, Tytgat GN. Acute primary HIV-esophagitis. Endoscopy. 1990;22:184-5.
6. Ho DD, Sarngadharan MG, Resnick L, Dimarzoveronese F, Rota TR, Hirsch MS. Primary human T-lymphotropic virus type III infection. Ann Intern Med. 1985;103(6 Pt 1):880-3.
7. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993;259:1749-54.
8. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991;324:961-4.
9. Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991;324:954-60.
10. Henrard DR, Daar E, Farzadegan H, Clark SJ, Phillips J, Shaw GM, et al. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:305-10.
11. Lee TH, Sheppard HW, Reis M, Dondero D, Osmond D, Busch MP. Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr. 1994;7:381-8.
12. McElrath MJ, Corey L, Greenberg PD, Matthews TJ, Montefiori DC, Rowen L, et al. Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen. Proc Natl Acad Sci U S A. 1996;93:3972-7.